Dublin, May 15, 2024 (GLOBE NEWSWIRE) — The “Global Lipid Nanoparticle Raw Materials Market Size, Share & Trends Analysis Report by Application (Therapeutics, Research), Product (Kits, Reagents), Disease Indication, End-use, Region, and Segment Forecasts, 2024-2030” report has been added to ResearchAndMarkets.com’s offering.
The global lipid nanoparticle raw materials market is poised for substantial growth over the coming years, with expectations to ascend to USD 329.2 million by the year 2030, growing at a compound annual growth rate (CAGR) of 5.66% from 2024. Market expansion is driven by increasing demands for efficient drug delivery systems, cutting-edge healthcare technology advancements, and a rising incidence of chronic diseases.
The therapeutic applications are leading the market, thanks to burgeoning collaborations between research institutions and industry players, as well as the influx of government funding. Within the product segment, kits have dominated market share, though reagents are projected to witness notable growth over the forecast period.
Advancements in Delivery Systems Fuel Growth
Notably, the infectious disease segment has demonstrated market dominance, forecasted to grow rapidly through 2030. The impetus provided by the development of COVID-19 vaccines through LNP-based delivery systems has brought substantial investment and innovation to the forefront.
Challenges to Market Progress
Intellectual property rights pose challenging barriers to new market entrants, affecting the range of competition. The transition from lab-scale models to commercial production also presents challenges in maintaining product quality and optimizing yields, signaling a need for effective process and equipment validation as well as efficient supply chain logistics.
Regional Market Insights
With a revenue share of 40.34% in 2023, North America leads the global market, attributed to the significant burden of infectious diseases, high purchasing power parity, and extensive government healthcare support. The pharmaceutical & biotechnology companies segment leads the end-use market, owing to robust revenue shares.
Conversely, the academic & research institute segment is positioned for the fastest growth rate during the forecast period. This market trajectory suggests a cautiously optimistic outlook for stakeholders in the lipid nanoparticle raw materials sector, promising a dynamic evolution in line with technological advancements in drug delivery and healthcare innovation.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $224.5 Million |
| Forecasted Market Value (USD) by 2030 | $329.2 Million |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
Companies Featured
- Merck KGaA
- Echelon Biosciences
- BroadPharm
- Avanti Polar Lipids
- Tebubio
- Creative Biolabs
- CordenPharma International
- Biopharma PEG Scientific Inc.
- NOF AMERICA CORPORATION
- Polysciences, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/rnvz5w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Global Lipid Nanoparticle Raw Materials Market
